Anhui Huangshan Capsule Co., Ltd.

002817

CNE100002BV5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
6.35 ^CNY	-0.31%		-4.22%	-27.51%

Apr. 19	Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 25	Anhui Huangshan Capsule Co., Ltd. Proposes Final Cash Dividend for the Year 2023	CI

Anhui Huangshan Capsule Co., Ltd. has withdrawn its IPO.

May 07, 2015 at 12:00 am EDT

Latest news about Anhui Huangshan Capsule Co., Ltd.

Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Anhui Huangshan Capsule Co., Ltd. Proposes Final Cash Dividend for the Year 2023	Mar. 25	CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-10	CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Anhui Huangshan Capsule Co., Ltd. Announces Final Cash Dividend of A Shares for 2022, Payable on 07 June 2023	23-06-01	CI
Anhui Huangshan Capsule Co., Ltd. Approves 2022 Profit Distribution Plan	23-05-22	CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Anhui Huangshan Capsule Posts 12% Rise in 2022 Profit	23-02-20	MT
Anhui Huangshan Capsule Co., Ltd. Approves Board Elections	22-12-09	CI
Shandong Lutai Holding Group Co., Ltd. completed the acquisition of a 29.99% stake in Anhui Huangshan Capsule Co., Ltd. from Yu Chunming.	22-10-31	CI
Shandong Lutai Holding Group Co Ltd completed the acquisition of a 30% stake in Anhui Huangshan Capsule Co., Ltd..	22-10-25	CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-23	CI
Anhui Huangshan Capsule Discloses Change in Controlling Shareholder	22-10-05	MT
Shandong Lutai Holding Group Co Ltd agreed to acquire a 30% stake in Anhui Huangshan Capsule Co., Ltd. for CNY 1.1 billion.	22-09-28	CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-24	CI
Anhui Huangshan Capsule Co., Ltd. Announces Final Cash Dividend for the Year 2021	22-04-08	CI
Anhui Huangshan Capsule Bumps 2021 Dividend by 33% on Robust Earnings	22-03-14	MT
Anhui Huangshan Capsule Co., Ltd. Proposes Final Cash Dividend for the Year 2021	22-03-14	CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-25	CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-16	CI
Anhui Huangshan Capsule Co., Ltd. Announces 2020 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 09 June 2021	21-06-03	CI
Anhui Huangshan Capsule Co., Ltd. Approves Final Cash Dividend for the Year 2020	21-05-21	CI
Anhui Huangshan Capsule Co., Ltd. Proposes Final Cash Dividend for the Year 2020	21-04-28	CI
Zhongyuanfang Industrial Co., Ltd. signed an agreement to acquire 29.99% stake in Anhui Huangshan Capsule Co., Ltd. from Yu Chunming.	21-03-16	CI

Chart Anhui Huangshan Capsule Co., Ltd.

Duration

Period

More charts

Anhui Huangshan Capsule Co Ltd is a China-based company principally engaged in the manufacture and sales of hollow medical capsules. The Company's products mainly include gelatin hollow capsules and enteric gelatin hollow capsules. The Company is also engaged in the manufacture and sales of pharmaceutical equipment. The Company mainly distributes its products within domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-20 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ANHUI HUANGSHAN CAPSULE CO., LTD.	-27.51%	262M
ELI LILLY AND COMPANY	+38.51%	727B
NOVO NORDISK A/S	+33.05%	599B
JOHNSON & JOHNSON	-6.23%	354B
MERCK & CO., INC.	+18.78%	328B
ABBVIE INC.	+1.35%	277B
ASTRAZENECA PLC	+16.00%	243B
NOVARTIS AG	+8.09%	205B
ROCHE HOLDING AG	-5.77%	203B
AMGEN INC.	+6.19%	164B